Bristol-Myers Squibb (BMS) is a global biopharmaceutical company known for its innovative medicines and commitment to addressing unmet medical needs. The company's strategic focus on oncology, cardiovascular, immunoscience, and fibrosis has positioned it as a leader in the pharmaceutical industry. BMS's strong pipeline of new drugs, strategic acquisitions, and partnerships have bolstered its market position. However, the company faces challenges such as patent expirations, regulatory hurdles, and intense competition. To sustain growth, BMS must continue to innovate, navigate regulatory landscapes, and manage its financial health effectively.